ArticleScientific reports2026

Pretreatment tumor infiltrating lymphocytes and outcome in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.

Rosalba Torrisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.